Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer

被引：0
|
作者：
T Hamaoka
C M Costelloe
J E Madewell
P Liu
D A Berry
R Islam
R L Theriault
G N Hortobagyi
N T Ueno
机构：
[1] The University of Texas M. D. Anderson Cancer Center,Department of Stem Cell Transplantation and Cellular Therapy
[2] Breast Cancer,Department of Diagnostic Radiology
[3] St Luke's International Hospital,Department of Biostatistics and Applied Mathematics
[4] The University of Texas M. D. Anderson Cancer Center,Department of Breast Medical Oncology
[5] The University of Texas M. D. Anderson Cancer Center,undefined
[6] The University of Texas M. D. Anderson Cancer Center,undefined
来源：
British Journal of Cancer | 2010年 / 102卷
关键词：
bone diseases; breast neoplasms; diagnostic imaging; response assessment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：651 / 657
页数：6
相关论文
共 50 条
  • [1] Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer
    Hamaoka, T.
    Costelloe, C. M.
    Madewell, J. E.
    Liu, P.
    Berry, D. A.
    Islam, R.
    Theriault, R. L.
    Hortobagyi, G. N.
    Ueno, N. T.
    BRITISH JOURNAL OF CANCER, 2010, 102 (04) : 651 - 657
  • [2] Accurate tumor response assessment in bone-only metastatic breast cancer by comprehensive imaging and by new response criteria
    Hamaoka, T
    Costelloe, CM
    Madewell, JE
    Islam, R
    Rondon, G
    Ayers, GD
    Champlin, RE
    Berry, DA
    Hortobagyi, GN
    Ueno, NT
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S258 - S258
  • [3] Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria
    Trillet-Lenoir, V
    Freyer, G
    Kaemmerlen, P
    Fond, A
    Pellet, O
    Lombard-Bohas, C
    Gaudin, JL
    Lledo, G
    Mackiewicz, R
    Gouttebel, MC
    Moindrot, H
    Boyer, JD
    Chassignol, L
    Stremsdoerfer, N
    Desseigne, F
    Moreau, JM
    Hedelius, F
    Moraillon, A
    Chapuis, F
    Bleuse, JP
    Barbier, Y
    Heilmann, MO
    Valette, PJ
    BRITISH JOURNAL OF RADIOLOGY, 2002, 75 (899): : 903 - 908
  • [4] Prognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only Metastases
    Parkes, Amanda
    Warneke, Carla L.
    Clifton, Katherine
    Al-Awadhi, Aydah
    Oke, Oluchi
    Pestana, Roberto Carmagnani
    Alhalabi, Omar
    Litton, Jennifer K.
    Hortobagyi, Gabriel N.
    ONCOLOGIST, 2018, 23 (11): : 1282 - 1288
  • [5] Treatment response in metastatic breast cancer. A multicentre study comparing UICC criteria and tumour marker changes
    VanDalen, A
    Heering, KJ
    Barak, V
    Peretz, T
    Cremaschi, A
    Geroni, P
    Gion, M
    Saracchini, S
    Molina, R
    Namer, M
    Stieber, P
    Sturgeon, C
    Leonard, RCF
    Einarsson, R
    BREAST, 1996, 5 (02): : 82 - 88
  • [6] Complete response of bone-only metastatic breast cancer to skeletal:: Targeted radiotherapy with 166HOLMIUM-DOTMP.
    Booser, DJ
    Ueno, NT
    Rondon, G
    Williams, PA
    Wendt, R
    Hortobagyi, GN
    Podoloff, DA
    Champlin, RE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 21S - 21S
  • [7] Prolonged overall survival for patients with bone-only metastases at presentation of metastatic breast cancer
    Curtit, E.
    Bazan, F.
    Chaigneau, L.
    Mouillet, G.
    Dobi, E.
    Mansi, L.
    Meneveau, N.
    Paillard, M-J.
    Meynard, G.
    Klajer, E.
    Villanueva, C.
    Montcuquet, P.
    Pivot, X.
    Cals, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [8] The evolving molecular characterisation, histological criteria and nomenclature of adenoid ameloblastoma as a World Health Organisation tumour type
    Odell, Edward W.
    Gomes, Carolina Cavalieri
    Thavaraj, Selvam
    HISTOPATHOLOGY, 2024, 85 (06) : 846 - 852
  • [9] Real-world tumour response of palbociclib plus letrozole vs letrozole for metastatic breast cancer in US clinical practices
    Brufsky, A.
    Liu, X.
    Li, B.
    Mcroy, L.
    Layman, R. M.
    ANNALS OF ONCOLOGY, 2020, 31 : S79 - S79
  • [10] Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acid
    Yanaea, Masashi
    Fujimoto, Shinichiro
    Tane, Kaori
    Tanioka, Maki
    Fujiwara, Kimiko
    Tsubaki, Masanobu
    Yamazoe, Yuzuru
    Morishima, Yoshiyuki
    Chiba, Yasutaka
    Takao, Shintaro
    Komoike, Yoshifumi
    Tsurutani, Junji
    Nakagawa, Kazuhiko
    Nishida, Shozo
    JOURNAL OF BONE ONCOLOGY, 2017, 8 : 18 - 22
12345